NEWGENE Products Show Superior Performance worldwide

Recently, NEWGENE novel coronavirus antigen detection products have passed the clinical validation in national labs in Switzerland, Kenya, Zimbabwe, Ecuador etc. NEWGENE products show good performance in sensitivity and specificity compared with international brand products.

Currently, NEWGENE product has got BfArM approval in Germany, and is under PEI clinical validation.

 

Attachment 1:Screenshot of clinical report in Switzerland

Attachment 2:Screenshot of clinical report in Kenya

Attachment 3:Screenshot of clinical report in Zimbabwe

Attachment 4:Screenshot of clinical report in Ecuador